Robertet SA

OTCPK:RBTE.F Stock Report

Market Cap: US$1.9b

Robertet Valuation

Is RBTE.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RBTE.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RBTE.F ($933.25) is trading below our estimate of fair value ($1053.84)

Significantly Below Fair Value: RBTE.F is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RBTE.F?

Key metric: As RBTE.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for RBTE.F. This is calculated by dividing RBTE.F's market cap by their current earnings.
What is RBTE.F's PE Ratio?
PE Ratio21x
Earnings€86.35m
Market Cap€1.81b

Price to Earnings Ratio vs Peers

How does RBTE.F's PE Ratio compare to its peers?

The above table shows the PE ratio for RBTE.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.6x
MTX Minerals Technologies
16.7x23.1%US$2.6b
SCL Stepan
36.9x52.5%US$1.7b
IOSP Innospec
20.2x6.9%US$3.0b
KWR Quaker Chemical
24.3x18.3%US$3.0b
RBTE.F Robertet
21x8.0%US$1.8b

Price-To-Earnings vs Peers: RBTE.F is good value based on its Price-To-Earnings Ratio (21x) compared to the peer average (24.6x).

Price to Earnings Ratio vs Industry

How does RBTE.F's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$10.15m
BON Bon Natural Life
2.3xn/aUS$5.64m
GSPI Green Star Products
1.7xn/aUS$1.49m
RBTE.F 21.0xIndustry Avg. 23.3xNo. of Companies8PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: RBTE.F is good value based on its Price-To-Earnings Ratio (21x) compared to the US Chemicals industry average (23.3x).

Price to Earnings Ratio vs Fair Ratio

What is RBTE.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RBTE.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate RBTE.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst RBTE.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$933.25
US$1,154.51
+23.7%
4.1%US$1,210.65US$1,094.85n/a3
Nov ’25n/a
US$1,214.87
0%
4.1%US$1,273.96US$1,152.10n/a3
Oct ’25US$1,103.55
US$1,214.87
+10.1%
4.1%US$1,273.96US$1,152.10n/a3
Sep ’25n/a
US$1,218.92
0%
4.1%US$1,278.20US$1,155.94n/a3
Aug ’25n/a
US$1,221.50
0%
2.2%US$1,248.64US$1,194.35n/a2
Jul ’25n/a
US$1,210.77
0%
1.3%US$1,227.06US$1,194.48n/a2
Jun ’25n/a
US$1,210.77
0%
1.3%US$1,227.06US$1,194.48n/a2
May ’25n/a
US$1,193.28
0%
1.3%US$1,209.33US$1,177.23n/a2
Apr ’25US$875.00
US$1,121.05
+28.1%
3.8%US$1,164.17US$1,077.93n/a2
Mar ’25n/a
US$1,121.05
0%
3.8%US$1,164.17US$1,077.93n/a2
Feb ’25n/a
US$1,121.34
0%
3.4%US$1,159.26US$1,083.42n/a2
Jan ’25n/a
US$1,121.34
0%
3.4%US$1,159.26US$1,083.42n/a2
Dec ’24n/a
US$1,129.42
0%
3.4%US$1,167.61US$1,091.23n/a2
Nov ’24n/a
US$1,160.64
0%
9.5%US$1,310.96US$1,048.77n/a3
Oct ’24n/a
US$1,234.96
0%
7.8%US$1,330.78US$1,139.15US$1,103.552
Sep ’24US$860.76
US$1,279.80
+48.7%
7.3%US$1,373.17US$1,186.42n/a2
Aug ’24US$910.00
US$1,279.80
+40.6%
7.3%US$1,373.17US$1,186.42n/a2
Jul ’24US$925.00
US$1,279.80
+38.4%
7.3%US$1,373.17US$1,186.42n/a2
Jun ’24US$935.00
US$1,279.80
+36.9%
7.3%US$1,373.17US$1,186.42n/a2
May ’24n/a
US$1,279.80
0%
7.3%US$1,373.17US$1,186.42n/a2
Apr ’24n/a
US$1,234.76
0%
7.3%US$1,324.85US$1,144.67US$875.002
Mar ’24US$955.00
US$1,258.84
+31.8%
6.4%US$1,339.19US$1,178.49n/a2
Feb ’24n/a
US$1,114.45
0%
8.7%US$1,211.36US$1,017.54n/a2
Jan ’24n/a
US$1,114.45
0%
8.7%US$1,211.36US$1,017.54n/a2
Dec ’23n/a
US$1,114.45
0%
8.7%US$1,211.36US$1,017.54n/a2
Nov ’23n/a
US$1,114.45
0%
8.7%US$1,211.36US$1,017.54n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Trinseo

US$122.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.40

7D

-7.9%

1Y

-50.1%

Huntsman

US$3.4b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.47

7D

-2.6%

1Y

-21.8%

CMOC Group

HK$162.2b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.81

7D

-8.0%

1Y

41.7%